Valeant Pharma (VRX) option implied volatility elevated into Q1 and outlook

Valeant Pharma (NYSE: VRX) May weekly call option implied volatility is at 117, May is at 80, June is at 55; compared to its 52-week range of 41 to 87 into the expected release of Q1 results before the open on May 8.

You May Also Be Interested In

• BYD: June total production volume 403,246 units
• Intel (INTC) August calls active, share price up 4%
• National Energy Services Reunited Corp. (NESR) 5400 contracts of July 35 calls trade, share price up 3.9%